Fumiya Watanabe, Keiji Fujiwara, Koji Furuuchi, Masashi Ito, Kazuhiko Hanada, Tatsuya Kodama, Akio Aono, Satoshi Mitarai, Kozo Morimoto. Safety and efficacy of clofazimine are correlated with its serum concentration: Findings of a prospective observational study for pulmonary nontuberculous mycobacterial disease. Tuberculosis and non-tuberculous mycobacterial diseases. 2024. OA1982-OA1982
Kunhyung Bahk, Joohon Sung, Mitsuko Seki, Kyungjong Kim, Jina Kim, Hongjo Choi, Jake Whang, Satoshi Mitarai. Pan-lineage Mycobacterium tuberculosis reference genome for enhanced molecular diagnosis. DNA Research. 2024. 31. 4
Fumiya Watanabe, Yasuhiko Matsumoto, Takashi Sugita, Yuta Morishige, Satoshi Mitarai, Yoshihiko Hoshino, Kazuhiko Hanada. Pharmacokinetics of anti-Mycobacterium avium-intracellulare disease drugs in silkworms. Scientific Reports. 2024. 14. 1
Izumi Yamatani, Akio Aono, Keiji Fujiwara, Takahiro Asami, Keisuke Kamada, Yuta Morishige, Yuriko Igarashi, Kinuyo Chikamatsu, Yoshiro Murase, Hiroyuki Yamada, et al. In vitro effects of the new oral β-lactamase inhibitor xeruborbactam in combination with oral β-lactams against clinical Mycobacterium abscessus isolates. Microbiology spectrum. 2024. e0008424
Fumiya Watanabe, Keiji Fujiwara, Koji Furuuchi, Masashi Ito, Kazuhiko Hanada, Tatsuya Kodama, Akio Aono, Satoshi Mitarai, Takashi Yoshiyama, Atsuyuki Kurashima, et al. Clofazimine Serum Concentration and Safety/Efficacy in Nontuberculous Mycobacterial Pulmonary Disease Treatment. Respiratory Medicine. 2024. 107718-107718
Automatous quantitative MICs determination of Mycobacteria using a reducing chromogenic reagent WST-1
(International Union against Tuberculosis and Lung Diseases 2023)
Evaluation of Deeplex-MycTB using clinical specimens in Japan
(International Union against Tuberculosis and Lung Diseases 2023)
In vitro activity of tedizolid and linezolid against multidrug-resistant Mycobacterium tuberculosis
(International Union against Tuberculosis and Lung Diseases 2023)
Evaluation of the Lung Flute ECO to assist in sputum collection among people with presumptive tuberculosis: a randomized crossover trial
(International Union against Tuberculosis and Lung Diseases 2023)